Source: Annual Congress 2004 - Pleural effusions
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
T. Bakirci, S. Alpar, N. Ucar, A. S. Turgut, B. Dursun, D. Sertkaya, B. Kurt (Ankara, Turkey). The diagnostic value of vascular endothelial growth factor in pleural effusion. Eur Respir J 2004; 24: Suppl. 48, 1605

Member's Comments

No comment yet.

Related content which might interest you: Vascular endothelial growth factor in pleural effusions of different origin Source: Eur Respir J 2005; 25: 600-604 Year: 2005 Vascular endothelial growth factor (VEGF) in malignant and tuberculous pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 397s Year: 2001 The role of vascular endothelial growth factor in tuberculous and parapneumonic pleural effusions Source: Annual Congress 2008 - Pleural diseases and interventions Year: 2008 Is pleural VEGF a useful parameter? Source: Annual Congress 2007 - Pleural malignancy Year: 2007 The clininical value of vascular endothelial growth factor (VEGF) in the development of lung sarcoidosis. Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018 Serum levels of vascular endothelial growth factor in the differential diagnosis of pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 210s Year: 2002 Diagnostic value of vascular endothelial growth factor, glycosaminoglycan, cathepsin S, cathepsin H in the discrimination of transudate exudate and benign malignant patients with pleural effusion Source: Annual Congress 2012 - Diagnosis and biology of malignant pleural effusions Year: 2012 Dasatinib increases endothelial permeability leading to pleural effusion Source: Eur Respir J, 51 (1) 1701096; 10.1183/13993003.01096-2017 Year: 2018 Dasatinib increases endothelial permeability leading to pleural effusion Source: International Congress 2017 – Experimental PH Year: 2017 Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma Source: Eur Respir J 2008; 32: 924-930 Year: 2008 Anti-vascular endothelial growth factor decreases pleural adhesions in experimental pleurodesis induced by silver nitrate Source: Annual Congress 2007 - Pleural diseases Year: 2007 Can VEGF be used in differential diagnosis of pleural effusions? Source: Eur Respir J 2007; 30: Suppl. 51, 565s Year: 2007 Reumathoid factor: diagnostic utility in pleural fluid Source: Eur Respir J 2003; 22: Suppl. 45, 191s Year: 2003 MMP expression and abnormal lung permeability are important determinants of outcome in IPF Source: Eur Respir J 2009; 33: 77-84 Year: 2009 Profibrotic implication of platelet-activating factor in tuberculous pleural effusion Source: Virtual Congress 2020 – Translational therapeutic advances Year: 2020 Vascular endothelial growth factor levels in active pulmonary tuberculosis Source: Eur Respir J 2002; 20: Suppl. 38, 610s Year: 2002 Epidermal growth factor in the lungs of infants developing chronic lung disease Source: Eur Respir J 2001; 18: 796-800 Year: 2001 The value of IL6 in differentiation between malignant and non malignant pleural effusion Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience Year: 2009 Vascular endothelial growth factor (VEGF) and bronchial wall remodelling in asthma Source: Annual Congress 2004 - Genetics and molecular mechanisms of COPD and asthma Year: 2004